Management of Neurogenic Orthostatic Hypotension

被引:9
|
作者
Arbique, Debbie [1 ]
Cheek, Dennis [2 ,3 ]
Welliver, Mark [2 ,3 ]
Vongpatanasin, Wanpen [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Div Cardiol, Hypertens Sect, Dallas, TX 75390 USA
[2] Texas Christian Univ, Harris Coll Nursing & Hlth Sci, Ft Worth, TX 76129 USA
[3] Texas Christian Univ, Sch Nurse Anesthesia, Ft Worth, TX 76129 USA
关键词
Neurogenic orthostatic hypotension; physiology and pathophysiology with standing; supine hypertension; neurogenic; diagnostic tests; pharmacological and nonpharmacological; mortality; morbidity; BLOOD-PRESSURE; AUTONOMIC DYSFUNCTION; ATHEROSCLEROSIS RISK; WATER DRINKING; PATHOPHYSIOLOGY; HYPERTENSION; ADULTS; MIDODRINE; DIAGNOSIS; SYNCOPE;
D O I
10.1016/j.jamda.2013.10.014
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The burden of orthostatic hypotension (OH) on public health is a universally recognized enigmatic clinical condition that is associated with significant increases on morbidity and mortality rates, and can take a major toll on one's quality of life. Orthostatic hypotension is predictive of vascular deaths from acute myocardial infarction, strokes in the middle aged population, and increases mortality rates when associated with diabetes, hypertension, Parkinson's disease, and patients receiving renal dialysis. The consensus definition for OH is a fall in systolic blood pressure of at least 20 mm Hg and/or diastolic blood pressure of at least 10 mm Hg within 3 minutes of quiet standing. Because neurogenic OH is often accompanied by supine hypertension, the treatment program should aim toward minimizing OH and the potential fall injuries related to cerebral hypoperfusion without exacerbating nocturnal hypertension that may lead to excessive cardiovascular complications. (C) 2014 - American Medical Directors Association, Inc. All rights reserved.
引用
收藏
页码:234 / 239
页数:6
相关论文
共 50 条
  • [21] Droxidopa for neurogenic orthostatic hypotension
    Cheshire, William P.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (12): : 1479 - 1490
  • [22] Recognition, Diagnosis, and Management of Neurogenic Orthostatic Hypotension in Older Individuals
    Hewitt, L.
    Widolff, M.
    Ziemann, A.
    Harrison, T.
    Vernino, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S191 - S192
  • [23] INSULIN-INDUCED HYPOTENSION AND NEUROGENIC ORTHOSTATIC HYPOTENSION
    BROWN, RT
    POLINSKY, RJ
    LEE, GK
    DEETER, JA
    NEUROLOGY, 1986, 36 (10) : 1402 - 1406
  • [24] Treatment of Patients with Neurogenic Orthostatic Hypotension
    Simona Maule
    Mirko Tredici
    Sara Del Colle
    Livio Chiandussi
    High Blood Pressure & Cardiovascular Prevention, 2003, 10 (2) : 95 - 103
  • [25] Neurogenic orthostatic hypotension: chasing "the fall''
    Gupta, D.
    Nair, M. D.
    POSTGRADUATE MEDICAL JOURNAL, 2008, 84 (987) : 6 - 14
  • [26] Neurogenic orthostatic hypotension: the very basics
    Kaufmann, Horacio
    Palma, Jose-Alberto
    CLINICAL AUTONOMIC RESEARCH, 2017, 27 : 39 - 43
  • [27] Factors Contributing To Postprandial Hypotension In Neurogenic Orthostatic Hypotension
    Mehr, Pouya E.
    Hay, Kaitlyn R.
    Castro, Robert
    Ding, Tan
    Claassen, Daniel O.
    Biaggioni, Italo
    Peltier, Amanda
    Shibao, Cyndya A.
    HYPERTENSION, 2023, 80
  • [28] Droxidopa (Northera) for Neurogenic Orthostatic Hypotension
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 92 - 93
  • [29] Neurogenic orthostatic hypotension induced by tizanidine
    Maureen C. Farrell
    Italo Biaggioni
    Cyndya A. Shibao
    Clinical Autonomic Research, 2020, 30 : 173 - 175
  • [30] Neurogenic Orthostatic Hypotension A Pathophysiological Approach
    Goldstein, David S.
    Sharabi, Yehonatan
    CIRCULATION, 2009, 119 (01) : 139 - 146